Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors |
Mechanism CDK19 inhibitors(Cyclin-dependent kinase 19 inhibitors), CDK8 inhibitors(Cyclin-dependent kinase 8 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC22H22ClN7O |
InChIKeyYLJSAFSDGFNKAC-UHFFFAOYSA-N |
CAS Registry2648453-53-4 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Neoplasms | Preclinical | United States | 26 Nov 2019 | |
| Neurodegenerative Diseases | Preclinical | United States | 26 Nov 2019 |





